888-776-0942 from 8 AM - 10 PM ET
Highly multiplexed, patented and patent-pending GT-Plex™ PCR assays for low-level, reliable mutation detection Endometrial Polyps Ultrasound
These kits are for Research Use Only (RUO) Not for use in diagnostic purposes
FORT COLLINS, Colo. , June 1, 2023 /PRNewswire/ --
GT Molecular, Inc., a company providing ultrasensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology testing is entering the cancer molecular assay market with multi-target PCR kits featuring robust quality control metrics and internal process controls. The first two RUO panels are for the EGFR activating mutations and the KRAS G12C target which are common in human cancers. These assay kits are designed and optimized for the Bio-Rad QX200™ and QX600™ Droplet Digital™ PCR Systems. Additional panels will follow for leading PCR platforms.
Additional offerings from GT Molecular include:
The company is empowering hundreds of academic, commercial, and public testing laboratories around the world with its easy-to-use and accurate PCR assay kits as well as its national testing and sequencing services.
With its GT-Plex™ patented and patent-pending technology, GT Molecular is a leader in providing ultrasensitive, multiplexed digital PCR and qPCR tests. GTM's technology for highly multiplexed assays provides a user friendly, out-of-box solution for rapid deployment with reliable and consistent measurements while detecting as little as 3-4 molecules of target nucleic acid. In addition to its presence in wastewater-based epidemiology, the company has a growing catalog that includes multiplexed PCR Kits for oncology genes and pathogen detection – including respiratory panels, SARS-CoV-2 + Variants, and others. For more information, please visit us at www.gtmolecular.com and follow us on LinkedIn and Twitter.
https://www.linkedin.com/company/gt-molecular/ https://twitter.com/GT Molecular
More news releases in similar topics
Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!
Wsu Molecular Lab Cision Distribution 888-776-0942 from 8 AM - 9 PM ET